Resistance of Staphylococcus aureus to vancomycin in Zarqa, Jordan

Pakistan Journal of Medical Sciences

Volumn 22, Issue 2, 2006, Pages 144-148

  Bataineh, Hussein Azzam ^a,b  

^a Royal Medical Services   (Jordan)

^b NONE   (Jordan)

Author keywords

MRSA; Staphylococcus aureus; Vancomycin

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEFALOTIN; CEFAZOLIN; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; OXACILLIN; PENICILLIN G; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG SENSITIVITY; JORDAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 33744481288     PISSN: 1682024X     EISSN: 1682024X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. CDC. National Nosocomial Infections Surveillance report, data summary from October 1986-April 1996, issued May 1996. Am J Infect Control 1996; 24: 380-8.
2. Waldvogel FA. Staphylococcus aureus (including toxic shock syndrome). In: Mandell GL, Bennett JE, Dolin R, eds.Mandell,Douglas and Bennett's principles and practice of infectious diseases, 4th ed. New York: Churchill Livingstone 1995; 1754-77.
3. Hiramatsu K, Hanaki H, Ino T, Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-6.
4. National Nosocomial Infections Surveillance (NNIS) System report,data summary from January1990-May1999,issued June 1999. Am J Infect Control 2001; 29: 404-21.
5. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
6. Maranan MC, Moreira B, Boyle-Vavra S, Daum RS. Antimicrobial resistance in staphylococci. Epidemiology, molecular mechanisms, and clinical relevance. Infect Dis Clin North Am 1997; 11: 813-49.
7. Ena J, Dick RW, Jones RN et al.The epidemiology of intravenous vancomycin usage in a university hospital: a 10-year study. JAMA 1993; 269: 598-602.
8. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6th ed. Approved standard, M7-A6. Wayne, Pennsylvania; 2003.
9. Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus: Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999; 340: 493-501.
10. Denis O, Nonhoff C, Byl B, Knoop C, Bobin-Dubreux S, Struelens MJ. Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features. J Antimicrob Chemother 2002; 50: 383-91.
11. Bierbaum G, Fuchs K, Lenz W, Szekat C, Sahl HG. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur J Clin Microbiol Infect Dis 1999; 18: 691-6.
12. Assadullah S, Kakru DK, Thoker MA, Bhat FA, Hussain N, Shah A. Emergence of low level vancomycin resistance in MRSA. Indian J Med Microbiol 2003; 21: 196-98.
13. No authors listed. Vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 902.
14. Perl TM. The threat of vancomycin resistance. Am J Med 1999; 106: 26S-37S.
15. Schweiger ES, Scheinfeld NS, Tischler HR, Weinberg JM. Linezolid and quinupristin/dalfopristin: novel antibiotics for Gram-positive infections of the skin. J Drugs Dermatol 2003; 2: 378-83.
16. Srinivasan A, Dick JD, Perl TM. Vancomycin resistance in staphylococci. Clin Microbiol Rev 2002; 15: 430-8.
17. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 8th ed. Approved standard, M2-A8. Wayne, Pennsylvania; 2003.
18. Suwanna T, Somwang D, Yong R, et al. First Report of Methicillin- Resistant Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Thailand. Journal of Clinical Microbiology 2001; 39: 591-95.
19. Noble WC, Virani Z, Cree RG. Cotransfer of vancomycin and other resistant genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 72: 195-98.
20. No authors listed. Staphylococcus aureus resistant to vancomycin - the United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 565-67.
21. Wootton M, Howe RA, Walsh TR, Bennett PM, MacGowan AP. In vitro activity of 21 antimicrobials against vancomycin-resistant Staphylococcus aureus (VRSA) and hetero-VRSA (hVRSA). J Antimicrob Chemother 2002; 50: 760-61.